These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36263897)

  • 21. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Aktaa S; Wu J; Nadarajah R; Rashid M; de Belder M; Deanfield J; Mamas MA; Gale CP
    Thromb Res; 2021 Jun; 202():17-23. PubMed ID: 33711754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
    Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19.
    Farrar JE; Trujillo TC; Mueller SW; Beltran L; Nguyen C; Hassell K; Kiser TH
    J Thromb Thrombolysis; 2022 Feb; 53(2):446-453. PubMed ID: 34410561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study.
    Arachchillage DJ; Rajakaruna I; Odho Z; Crossette-Thambiah C; Nicolson PLR; Roberts LN; Allan C; Lewis S; Riat R; Mounter P; Lynch C; Langridge A; Oakes R; Aung N; Drebes A; Dutt T; Raheja P; Delaney A; Essex S; Lowe G; Sutton D; Lentaigne C; Sayar Z; Kilner M; Everington T; Shapiro S; Alikhan R; Szydlo R; Makris M; Laffan M
    Br J Haematol; 2022 Jan; 196(1):79-94. PubMed ID: 34500500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study.
    Al Harbi S; Kensara R; Aljuhani O; Korayem GB; Altebainawi AF; Al Harthi A; Vishwakarma R; Alenazi AM; Almutairi A; Alshaya O; Alraddadi S; Al Sulaiman T; Aldakkan L; Mahboob R; Alaamer K; Alissa A; Hafiz A; Aldhayyan N; Althewaibi S; Alenezi F; Alkhotani NY; Alghamdi SA; Alenazi AA; Al Sulaiman K
    Clin Appl Thromb Hemost; 2022; 28():10760296221103864. PubMed ID: 35658686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
    Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
    JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19-related dynamic coagulation disturbances and anticoagulation strategies using conventional D-dimer and point-of-care Sonoclot tests: a prospective cohort study.
    Premkumar M; Loganathan S; Kajal K; Hazarika A; Soni S; Puri GD; Sehgal IS; Suri V; Malhotra P; Singh V; Duseja A; Bhalla A; Ahluwalia J; Kumar N; Kekan K; Ram S; Singla K; Mahajan V; Yaddanapudi N
    BMJ Open; 2022 May; 12(5):e051971. PubMed ID: 35501097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis.
    Demelo-Rodriguez P; Farfán-Sedano AI; Pedrajas JM; Llamas P; Sigüenza P; Jaras MJ; Quintana-Diaz M; Fernández-Capitán C; Bikdeli B; Jiménez D; Monreal M;
    J Thromb Haemost; 2021 Aug; 19(8):1981-1989. PubMed ID: 34018658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients.
    Russell L; Madsen MB; Dahl M; Kampmann P; Perner A
    Acta Anaesthesiol Scand; 2018 Feb; 62(2):196-206. PubMed ID: 29124749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status.
    Li W; Xu Z; Xiang H; Zhang C; Guo Y; Xiong J
    Aging (Albany NY); 2021 Mar; 13(7):9225-9242. PubMed ID: 33818421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19.
    Albisinni R; Vitrone M; Ursi MP; Spiezia S; Salemme A; Florio LL; Boccia F; Iossa D; Zampino R; Atripaldi L; Squillante F; Maturo N; Fraganza F; Severino S; Punzi R; Fiorentino G
    Blood Transfus; 2022 Nov; 20(6):495-504. PubMed ID: 36469432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.
    Katsoularis I; Fonseca-Rodríguez O; Farrington P; Jerndal H; Lundevaller EH; Sund M; Lindmark K; Fors Connolly AM
    BMJ; 2022 Apr; 377():e069590. PubMed ID: 35387772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboembolic risk in pregnant women with SARS-CoV-2 infection - A systematic review.
    Leal D; Ferreira J; Mansilha A
    Taiwan J Obstet Gynecol; 2022 Nov; 61(6):941-950. PubMed ID: 36427996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19.
    Li P; Zhao W; Kaatz S; Latack K; Schultz L; Poisson L
    JAMA Netw Open; 2021 Nov; 4(11):e2135397. PubMed ID: 34807256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes over time in characteristics, resource use and outcomes among ICU patients with COVID-19-A nationwide, observational study in Denmark.
    Haase N; Plovsing R; Christensen S; Poulsen LM; Brøchner AC; Rasmussen BS; Helleberg M; Jensen JUS; Andersen LPK; Siegel H; Ibsen M; Jørgensen VL; Winding R; Iversen S; Pedersen HP; Madsen J; Sølling C; Garcia RS; Michelsen J; Mohr T; Michagin G; Espelund US; Bundgaard H; Kirkegaard L; Smitt M; Buck DL; Ribergaard NE; Pedersen HS; Christensen BV; Nielsen LP; Clapp E; Jonassen TB; Weihe S; la Cour K; Nielsen FM; Madsen EK; Haberlandt TN; Meier N; Perner A
    Acta Anaesthesiol Scand; 2022 Sep; 66(8):987-995. PubMed ID: 35781689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes in COVID-19 patients admitted to intensive care in Denmark: A nationwide observational study.
    Meier N; Perner A; Plovsing R; Christensen S; Poulsen LM; Brøchner AC; Rasmussen BS; Helleberg M; Jensen JUS; Andersen LPK; Siegel H; Ibsen M; Jørgensen VL; Winding R; Iversen S; Pedersen HP; Sølling C; Garcia RS; Michelsen J; Mohr T; Michagin G; Espelund US; Bundgaard H; Kirkegaard L; Smitt M; Sigurdsson S; Buck DL; Ribergaard NE; Pedersen HS; Toft MH; Jonassen TB; Mølgaard Nielsen F; Madsen EK; Haberlandt TN; Bredahl LS; Haase N
    Acta Anaesthesiol Scand; 2023 Oct; 67(9):1239-1248. PubMed ID: 37288935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study.
    Deitelzweig S; Luo X; Nguyen JL; Malhotra D; Emir B; Russ C; Li X; Lee TC; Ferri M; Wiederkehr D; Reimbaeva M; Barnes GD; Piazza G
    J Thromb Thrombolysis; 2022 May; 53(4):766-776. PubMed ID: 35489004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.